MTC Reassured on Medicines Situation

2019-06-17 18:37:48.000 | view 359 | share : |

   Khartoum, June 17 (SUNA) A delegation from the Military Transitional Council was reassured during its visit Monday on the situation of the medicines at the Fund of Medical Supplies.

The head of the Economic Committee of the MTC Maj, Gen. Ibrahim Jabir Ibrahim has indicated satisfaction over the situation of the medicines after he toured the drug stores, the control room and various sections of the National Fund for Medical Supplies.

He affirmed the existence of a firm coordination and management of the quantities of medicines in the stores to provide medicines for public hospitals and pharmacies.

In a meeting attended by the Undersecretary of the Federal Ministry of Health, the Director of Medical Supplies Fund and all departmental directors, the Chairman of the Economic Committee of the TMC commended the supplies and pharmaceutical companies for the development of supplies to the rest of the governmental institutions.

Maj. Gen. Ibrahim has suggested the upgrading of the medical supplies fund to a research center in pharmacy sciences, disclosing an agreement with pharmaceutical companies to help increase drug production and export of medicine to neighboring countries, while pharmaceutical companies have pledged to fill gaps and provide all life-saving medicines for the medical supplies fund.

On his part, the Undersecretary of the Federal Ministry of Health Dr. Sulaiman Abdul-Jabbar has expected the increase in pharmaceuticals supplies to 95%, indicating the start of importing drugs after solving the problem of the companies’ debts with the support of the MTC.

The Director of Medical Supplies Fund, Abdul Rahman al-Ja’ali reassured situation of the medicines situation, stressing continuation of the surgical operations in hospitals.

He said that the fund aims to achieve medical security, provide medical products, enhance medicines availability and support the national industry, in addition the improving of the availability of medicines, pointin out that the fund prices are 47% lower than the prices of the private sector.